Annual Drug Patent Expirations for ALPHAGAN+P
Alphagan P is a drug marketed by Allergan and is included in two NDAs. It is available from one supplier. There are eight patents protecting this drug and two Paragraph IV challenges.
Drug patent litigation for ALPHAGAN P.
This drug has thirty-eight patent family members in nineteen countries.
The generic ingredient in ALPHAGAN P is brimonidine tartrate. One supplier is listed for this compound. Additional details are available on the brimonidine tartrate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
